MMP9 and melanoma: Other mechanisms involved the inhibition of cancer stem cells in one colorectal liver-metastatic model and suppression of MMPs (MMP2 and MMP9) in two lung metastatic models from SKOV-3 ovarian cancer and B16 melanoma.